Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Australian Stem Cell Centre (ASCC) was Australia's first biotechnology Centre of Excellence, established in 2002 to advance stem cell research and its clinical application. Operating as a consortium of leading universities and research institutes, the center focused on both embryonic and adult stem cell technologies to address unmet medical needs in areas such as hematology and cardiology. Key research programs were dedicated to developing cell-based therapies for conditions including blood disorders and heart disease. Funded significantly by the Australian Government, the ASCC played a pivotal role in establishing Australia's regulatory and ethical frameworks for stem cell science. The organization also focused on the commercialization of intellectual property derived from its member institutions. The ASCC transitioned its research programs and ceased operations as a standalone entity in 2011 following the conclusion of its government funding cycle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australian National Stem Cell Centre.